Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy

Cancer vaccines are increasingly being studied as a possible strategy to prevent and treat cancers. While several prophylactic vaccines for virus-caused cancers are approved and efficiently used worldwide, the development of therapeutic cancer vaccines needs to be further implemented. Virus-like par...

Full description

Bibliographic Details
Main Authors: Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, Arianna Palladini, Stefania Angelicola, Chiara Cappello, Olga Maria Pittino, Patrizia Nanni, Pier-Luigi Lollini
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
cancer immunotherapy
cancer immunoprevention
cancer vaccines
virus-like particles (VLPs)
tumor antigens
Online Access:https://www.mdpi.com/1422-0067/24/16/12963

Internet

https://www.mdpi.com/1422-0067/24/16/12963

Similar Items